August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Goutham Sunny: Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib
Apr 17, 2025, 06:24

Goutham Sunny: Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib

Goutham Sunny, Resident Doctor at The Gujarat Cancer and Research Institute, posted on X:

PALMARES-2 real world data shows Abemaciclib>Ribociclib>Palbociclib.

This data will definitely help in choosing between the CDK4/6i.”

“Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR+/HER2- BC patients: results from the multicenter PALMARES-2 study.”

Authors: L. Provenzano, M.V. Dieci, G. Curigliano, M. Giuliano, A. Botticelli, M. Lambertini, G. Rizzo, R. Pedersini, M. Sirico, N. La Verde, A. Gennari, A. Zambelli, A. Toss, M. Piras, M. Giordano, B. Tagliaferri, D. Generali, D. Sartori, D. Miliziano, A. Menichetti, F. Ligorio, C. Zurlo, G. Griguolo, P.P. Berton Giachetti, V. Faso, C. Corti, E. Chiappe, S. Scagnoli, S. Pisegna, C. Capasso, C. De Angelis, G. Arpino, C. Criscitiello, V. Guarneri, G. Pruneri, L. Mariani, C. Vernieri

Goutham Sunny: Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib